Impact Ethics

NTE Events Archive

Events, By Category and Date:

Subscribe - In Print

In Print

» Full news listing

Upcoming and most recent events are listed below in reverse order. For other archived events, please see the categories on the menu to the right, or 'View past items' to access archives by date.


nte  –  In Print
Friday, February 24, 2023
Matthew Herder and colleagues critically analyze the basis upon which Health Canada approved OxyContin.
nte  –  In Print
Friday, February 24, 2023
Matthew Herder and colleagues critically review the regulatory history of buprenorphine formulations in Canada.
nte  –  In Print
Thursday, February 23, 2023
Matthew Herder and colleagues publish on the topic of fair pricing and Canada's orphan drug policy.
nte  –  In Print
Monday, October 11, 2021
Françoise Baylis publishes a blog on ethical issues regarding heritable human genome editing.
nte  –  In Print
Tuesday, August 24, 2021
Françoise Baylis, Seema Mohapatra, and Natalie Kofler discuss concerns about the scientific, ethical, and practical risks associated with the broad use of COVID-19 vaccine credential programs, including racial discrimination and inequity at the hands of others.
nte  –  In Print
Monday, August 23, 2021
Matthew Herder, Alexander C. Egilman, and Joseph S. Ross discuss Health Canada's release of clinical information, how use of the data to date appears low and why increased use of these data could be invaluable.
nte  –  In Print
Monday, July 12, 2021
Françoise Baylis with colleagues from a WHO Expert Advisory Committee publish a global report for governance and oversight of human genome editing.
nte  –  In Print
Monday, July 12, 2021
Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish recommendations on human genome editing.
nte  –  In Print
Monday, July 12, 2021
Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish a position paper on human genome editing.
nte  –  In Print
Monday, June 7, 2021
Françoise Baylis and Sheetal Soni argue against reasons of expediency which would change the 14-day rule for research with human embryos.
View past items